Xeris Pharmaceuticals, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersChicago, IL
US patents25
SAM.gov UEIYAV5AK7VKJ31
CAGE code59FN0
Incorporated inDE
LEI5493001EPAB2LX05WW18
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
25 US patents granted 2012–2025, 10 of them in the five years to SEP 2025.
Pharmaceuticals 25
- Methods of treating disease with levoketoconazoleUS 12,377,096 · granted AUG 5, 2025
- Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameUS 11,964,003 · granted APR 23, 2024
- Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameUS 11,957,736 · granted APR 16, 2024
- Precipitation resistant small molecule drug formulationsUS 11,833,157 · granted DEC 5, 2023
- Methods for producing stable therapeutic glucagon formulations in aprotic polar solventsUS 11,590,205 · granted FEB 28, 2023
Newest 5 shown · Granted to Xeris Pharmaceuticals, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Xeris Pharmaceuticals, INC. | Chicago | IL | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.